Retrospective analysis on efficacy and safety of clinical application of sodium nitroprusside / 重庆医科大学学报
Journal of Chongqing Medical University
;
(12)1987.
Artigo
em Chinês
| WPRIM
| ID: wpr-574823
ABSTRACT
Objective:
To investigate the efficacy and safety of clinical use of sodium nitroprusside.Methods:
The data of 3894 hospitalized patients who had ever been treated with sodium nitroprusside between 1995 and 2004 in our hospital were retrospectively collected.The therapeutic dose,time of therapy,effective rate and side effect were assessed.Results:
The minimum time of continuous infusion with sodium nitroprusside was 0.5hour,the maximum 368 hours,average 125.5?24.2 hours.The minimum dose of sodium nitroprusside infusion was 0.2?g/(kg?min),the maximum 9.8?g/(kg?min),average 3.1?1.9?g/(kg?min).The minimum dose of continuous infusion was 2.5mg,the maximum 2050mg,average 210?26.7mg.Among the 3894 patients,3524 cases were effective,accounting for 90.4%;278 cases were ineffective,accounting for 7.1%;95 cases were death,amounting 2.4%,among which the cases caused by ssodium nitroprusside toxicity accounted for 0.02%.The total incidence of caused by sodium sodium nitroprusside toxicity accounted for 0.02%.The total incidence of common side effect was 13.7%.The incidence of hypotention,rebound and tolerance were 10.2%,3.2%,and 0.3% respectively,which might be prevented by some protective measures.Conclusion:
It is effective and safe for patients to undergo treatment with sodium nitroprusside.Sever toxicity is rare.Although the common side effect is frequent,but it can be controlled.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Chongqing Medical University
Ano de publicação:
1987
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS